| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| AEON Biopharma, Inc. | PRINCIPAL ACCOUNTING OFFICER | Class A Common Stock | 1,501,176 | $1,426,117 | $0.9500 | 04 Mar 2026 | Direct |
| AEON Biopharma, Inc. | PRINCIPAL ACCOUNTING OFFICER | Restricted Stock Units | 925,925 | 21 May 2025 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| AEON | AEON Biopharma, Inc. | 17 Feb 2026 | 2 | $0 | 4 | PRINCIPAL ACCOUNTING OFFICER | 05 Mar 2026, 18:06 |
| AEON | AEON Biopharma, Inc. | 21 May 2025 | 1 | $0 | 4 | Chief Accounting Officer | 23 May 2025, 16:55 |
| AEON | AEON Biopharma, Inc. | 31 Aug 2024 | 2 | $0 | 4 | PRINCIPAL ACCOUNTING OFFICER | 04 Sep 2024, 21:53 |
| AEON | AEON Biopharma, Inc. | 17 May 2024 | 0 | $0 | 3 | PRINCIPAL ACCOUNTING OFFICER | 24 May 2024, 20:02 |